- Home
- IHS vs OPK Comparison
IHS vs OPK Comparison
Compare IHS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHS
- OPK
- Stock Information
- Founded
- IHS 2001
- OPK 2007
- Country
- IHS United Kingdom
- OPK United States
- Employees
- IHS N/A
- OPK N/A
- Industry
- IHS Telecommunications Equipment
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- IHS Telecommunications
- OPK Health Care
- Exchange
- IHS Nasdaq
- OPK Nasdaq
- Market Cap
- IHS 2.4B
- OPK 1.0B
- IPO Year
- IHS 2021
- OPK 1995
- Fundamental
- Price
- IHS $6.94
- OPK $1.39
- Analyst Decision
- IHS Strong Buy
- OPK Buy
- Analyst Count
- IHS 7
- OPK 4
- Target Price
- IHS $10.18
- OPK $2.75
- AVG Volume (30 Days)
- IHS 500.7K
- OPK 2.0M
- Earning Date
- IHS 11-11-2025
- OPK 11-06-2025
- Dividend Yield
- IHS N/A
- OPK N/A
- EPS Growth
- IHS N/A
- OPK N/A
- EPS
- IHS 0.33
- OPK N/A
- Revenue
- IHS $1,731,025,000.00
- OPK $664,029,000.00
- Revenue This Year
- IHS $1.97
- OPK N/A
- Revenue Next Year
- IHS $5.50
- OPK $0.84
- P/E Ratio
- IHS $21.39
- OPK N/A
- Revenue Growth
- IHS N/A
- OPK N/A
- 52 Week Low
- IHS $2.44
- OPK $1.11
- 52 Week High
- IHS $7.66
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- IHS 47.01
- OPK 51.88
- Support Level
- IHS $6.88
- OPK $1.34
- Resistance Level
- IHS $7.66
- OPK $1.44
- Average True Range (ATR)
- IHS 0.25
- OPK 0.04
- MACD
- IHS -0.07
- OPK -0.00
- Stochastic Oscillator
- IHS 7.69
- OPK 50.00
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.